Genetic variation in DNA repair genes can modulate DNA repair capacity and may be related to cancer risk. However, study findings have been inconsistent. Inheritance of variant DNA repair genes is believed to influence individual susceptibility to the development of environmental cancer. Reliable knowledge on which the base excision repair (BER) sequence variants are associated with cancer risk would help elucidate the mechanism of cancer. Given that most of the previous studies had inadequate statistical power, we have conducted a systematic review on sequence variants in three important BER proteins. Here, we review published studies on the association between polymorphism in candidate BER genes and cancer risk. We focused on three key BER genes: 8-oxoguanine DNA glycosylase (OGG1), apurinic/apyrimidinic endonuclease (APE1/ APEX1) and x-ray repair cross-complementing group 1 (XRCC1). These specific DNA repair genes were selected because of their critical role in maintaining genome integrity and, based on previous studies, suggesting that single-nucleotide polymorphisms (SNPs) in these genes have protective or deleterious effects on cancer risk. A total of 136 articles in the December 13, 2010 MEDLINE database (National Center for Biotechnology Information, http://www.ncbi.nlm.nih.gov/pubmed/) reporting polymorphism in OGG1, XRCC1 or APE1 genes were analyzed. Many of the reported SNPs had diverse association with specific human cancers. For example, there was a positive association between the OGG1 Ser326Cys variant and gastric and lung cancer, while the XRCC1 Arg399Gln variant was associated with reduced cancer risk. Gene-environment interactions have been noted and may be important for colorectal and lung cancer risk and possibly other human cancers.
Introduction
There are two main types of DNA damages, endogenous and exogenous. Endogenous DNA damage is primarily caused by reactive oxygen species (ROS), which are the by-products of normal cellular metabolism. Exogenous DNA damage is caused by the environmental agents such as ultraviolet light, ionizing radiation and chemicals. 1 Some oxidative DNA lesions form at a high rate. For example, it is estimated that 100-500 8-hydroxyguanine (8-oxoG) lesions are formed per day in a human cell, 2 and formamidopyrimidine lesions (2,6-diamino-4hydroxy-5-formamidopyrimidine and 4,6-diamino-5formamidopyrimidine) form at a similar or higher rate in cells exposed to oxidative stress. 3 Oxidative damage to DNA, which also includes sugar modifications and strand breaks, can lead to transcription or replication defects, mutations, genomic instability and ultimately cellular dysfunction. In turn, cell stress pathways can induce apoptosis or support unregulated cell growth 4, 5 ( Figure 1 ) through the activation of oncogenes or inactivation of tumor suppressor genes. 6 Environmental chemicals and cancer; tobacco smoke as a model compound Most cancers are the result of the interactions of multiple genes and environmental factors. Tobacco smoke is a good example of an environmental risk factor for lung and other cancers. [7] [8] [9] Tobacco use is by far the most recognized link between exposure to known carcinogens and death from cancer, and like the aflatoxin-hepatocellular carcinoma relationship, can be considered a model for understanding mechanisms of cancer induction by exogenous chemical carcinogens. 10, 11 Tobacco smoke consists of at least 3800 chemical constituents, 12 including benzo[a]pyrene (BaP) and small chemical carcinogens, such as formaldehyde, ethylene oxide, benzene, 1,3-butadiene and many others. After biotransformation, the metabolites can induce oxidative stress or can covalently bind to DNA, leading to DNA modifications that can promote mutagenic bypass if unrepaired. 13 Tobacco smoke-induced DNA damage is repaired predominantly by base excision repair (BER, see more in The BER Pathway section) and nucleotide excision repair (NER).
In addition to DNA repair, xenobiotic metabolizing enzymes, that is, cytochromes, glutathione-S-transferase (GST) and N-acetyl-transferase, can modify the risk of exposure. However, in the absence of exposure, the presence or absence of these genetic risk factors is irrelevant. For example, both GSTM1 and GSTT1 genes can be deleted and their corresponding conjugating activity is absent without increased cancer risk, whereas functional polymorphisms in these genes may play a significant role in tobaccorelated cancer susceptibility. 14 There are also associations between DNA repair gene polymorphism and lung cancer, presumably because the genetic defects decrease capacity to remove potentially mutagenic BaP DNA adducts or other DNA lesions introduced by tobacco smoke. [15] [16] [17] [18] [19] [20] [21] Antioxidant defense systems and multiple DNA repair pathways have evolved to protect cells from oxidative stress and oxidative DNA damaging agents, acting as first and second lines of defense, respectively. 22, 23 The BER pathway BER is critical for genome maintenance, and defects in BER are related to cancer risk and premature aging. 24 BER is the main pathway for the repair of apurinic and apyrimidinic (AP) sites. 25 DNA singlestrand breaks as well as 8-oxoG, Fapy lesions or other base or sugar modifications arise via oxidation, alkylation or spontaneous decay. 26 BER is classically initiated by a DNA glycosylase, which cleaves the N-glycosyl bond, releasing the substrate base and generating an abasic site. The abasic site is then cleaved by an AP lyase or AP endonuclease and, at instances when repair is successfully executed, the one base gap in the cleaved DNA strand is filled-in by a DNA polymerase and ligated by a DNA ligase. 1, 27 Genetic susceptibility to cancer and DNA repair Single-nucleotide polymorphisms (SNPs) are the DNA base variants present in the human population at a frequency >1%. 28, 29 The nonsynonymous coding SNPs (nsSNPs) and SNPs in regulatory regions are believed to have the highest impact on phenotype. Both nsSNPs and regulatory SNPs in DNA repair genes can result in reduced DNA repair capacity, which can underlie a higher mutation rate and increased cancer risk. 30 If a polymorphism is in a repair gene that plays a pivotal role in the removal of oxidative DNA damage, for instance, the resulting reduced repair activity will increase the possibility of disease, particularly in the face of oxidative stress. Studies on polymorphisms, therefore, provide an opportunity to discover candidate susceptibility alleles. However, the functional outcome and phenotypic effect of some polymorphisms are unknown. This review focuses on the phenotypic effects of variants in three genes, which have important roles in BER, in the development of carcinogenesis.
This review examines possible effects on cancer risk from polymorphisms in three BER proteins: 8-oxoguanine DNA glycosylase 1 (OGG1), AP endonuclease 1 (APE1), and x-ray repair cross complementing group 1 (XRCC1). The OGG1 gene is located at 3p25 and encodes the major repair enzyme for 8-oxoG. 1245C>G is a well-characterized OGG1 polymorphism that results in substitution of serine with cysteine at codon 326. 31 Molecular epidemiologic case-control studies suggest that the hOGG1Cys326 allele is associated with a higher risk of developing several types of cancers. [32] [33] [34] [35] [36] In addition to catalyzing excision of 8-oxoG from DNA, OGG1 possesses the ability to incise at abasic sites via an AP lyase activity. It has been demonstrated that the OGG1 Cys326 protein repairs 8-oxoG inefficiently, leading to the hypothesis that this variant may contribute to a higher cellular mutation rate. 37 APE1 (also known as APE, APEX, HAP1 and REF-1) plays an essential role in BER. APE1 initiates repair of abasic sites in DNA by hydrolyzing the phosphodiester backbone 5 0 to an AP site. 38 Known sequence variants in APE1 include an amino acid change from aspartic acid to glutamic acid (Asp148Glu) in exon 5 that may be associated with hypersensitivity to ionizing radiation and cancer risk. [38] [39] [40] However, the Asp148Glu substitution did not alter APE1 AP site incision activity in vitro. 41 APE1 also plays a role in regulating the DNA binding capacity of several transcription factors and thus gene expression efficiency. As will be discussed further below, some studies show an influence of APE1 polymorphism on the prognosis of ovarian, gastrooesophageal and pancreatico-biliary cancer. 42 XRCC1 is an important scaffold protein that interacts with the enzymatic factors such as polyadenosine diphosphate (ADP)-ribose polymerase, DNA ligase III and DNA polymerase b to facilitate efficient repair of DNA single-strand breaks. 43 XRCC1 is located at 19q13.2 and consists of 17 exons encoding a 633 amino acid protein. A common genetic variant in XRCC1 (C>T) in exon 6 results in an Arg to Trp (rs25487) substitution at codon 194, while another polymorphism (G>A) in exon 10 changes amino acid Arg to Gln in codon 399 44 and yet another polymorphism (G>A) in exon 9 changes amino acid Arg to His (rs25489) in codon 280. 45 A variant XRCC1 gene may alter protein function and repair capacity, thus leading to genetic instability and carcinogenesis. However, the current data on the consequences of the 194 and 399 amino acid variants on XRCC1 function are complex. 37 Nevertheless, since any of the nsSNPs described above may represent functional polymorphisms, the possible influence of the polymorphic variants in OGG1, XRCC1 and APE1 on cancer risk is reviewed in further detail herein ( Figure 2 ).
Materials and methods
As will be discussed in much detail later, SNPs in some BER genes appear to confer greater susceptibility to environmentally induced cancers. While recent studies have begun to evaluate the effect of SNPs on the DNA repair and metabolizing genes on the treatment outcome, such analyses have not been included in this review. In this review, we conducted a PubMed search of published articles using the keywords 'OGG1, Ser326Cys or APE1, Asp148Glu or XRCC1, Arg399Gln, Arg194Trp, Arg280His and cancer'. A total of 136 articles were identified in the December 13, 2010 MEDLINE database (National Center for Biotechnology Information, PubMed database: http://www.ncbi.nlm.nih.gov/pubmed/). These specific gene polymorphisms were selected because of their high frequency and because of the large number of epidemiological studies examining their association with multiple cancers. Only quantitative studies were considered. Abstracts from scientific meetings were not reviewed. Studies with a sample size of <100 were excluded. There was no selection for specific cancer types. Odds ratios (ORs) for selected polymorphisms were tabulated and compared, primarily from case-control studies. Figure 3 presents inclusion/exclusion criteria. Forty-one articles did not meet the inclusion criteria (such as, studies on disease polymorphism, response to drug therapy polymorphism, occupational exposure to chemical polymorphisms, genotoxicity assays-polymorphism associations, etc.). Of the 136 articles, 76 met inclusion criteria. The articles included studies on 15 types of cancer ( Figure 4 ) and their association with OGG1, APE1 or XRCC1 gene polymorphisms. Of all the studies, 55% were conducted in Asian populations and 45% were conducted in Caucasian populations. Most of the studies were hospitalbased. Some cancer types were pooled and defined as one cancer type: oral/pharyngeal cancers and laryngeal cancers were pooled and defined as upper aerodigestive cancer (UADC); colon and colorectal cancer were pooled and defined as colon cancer; biliary tract and gallbladder cancer were pooled and defined as biliary tract cancer; mesothelioma, lung and non-small-cell lung carcinoma (NSCLC) were pooled and defined as lung cancer; precancerous gastric lesions, gastric cancer and gastric cardiac adenocarcinoma (ADC) were pooled and defined as gastric cancer; cervix, endometriosis and uterine leiomyoma were pooled and defined as gynecological cancer. In some articles, many different gene polymorphisms (more than 15 gene polymorphisms) and one cancer type association were studied. For these articles, only data relevant to OGG1, APE1 and XRCC1 SNPs are discussed in detail herein. Results of each study are given in Tables 1 to 8 and are discussed below. Since meat consumption and smoking are frequent in the Norwegian population, different gene-environment interactions are likely in both the types of population. 48 In another cohort study, in a Norwegian population, the association between XRCC1 gene polymorphisms (Arg194Trp, Arg280His and Arg399Gln) and the risk of colorectal adenomas and carcinomas was examined. This study demonstrated increased risk of advanced colorectal neoplasia in individuals with the XRCC1 Arg280His gene polymorphism and a reduced risk associated with the Arg399Gln gene polymorphism. 49 Moreno et al. investigated whether common polymorphisms in DNA repair genes correlate with colorectal cancer risk or patient prognosis and response to chemotherapy. In fact, adjuvant chemotherapy causes an acute increase in DNA damage, suggesting that the DNA repair capacity in specific cancer cells, tumors or individuals may influence the therapeutic efficacy of the selected DNA-interactive drugs. In the study, the incidence of 28 common SNPs in 15 DNA repair genes was determined in DNA from colorectal cancer patients. SNPs were examined in the following genes: BER (OGG1, LIG3, APE, POLB, XRCC1, PCNA and MUTYH), NER (ERCC1, ERCC4 and ERCC5), double-strand break repair (XRCC2, XRCC3 and XRCC9) and direct reversal repair (MGMT). The findings suggest that, among the BER genes, in contrast to the results of Hansen et al., homozygous carriers of OGG1 Ser/Cys had a statistically significant twofold higher risk of colorectal cancer than the carriers of the wild type allele (OR ¼ 2.31; 95% CI ¼ 1.05-5.09). The APE1 Asp148Glu variant was also associated with an increased risk of colorectal cancer (OR ¼ 3.04; 95% CI ¼ 1.38-6.71 for APE1 Asp148Glu). 50 In a subsequent study, no association was found with APE1 in colorectal cancer, but the risk was increased in colon cancer for the Glu/Glu genotype. For OGG1 Ser326Cys, a significantly increased risk was observed in smokers. Interestingly, the joint effect of variant alleles of APE1 Asp/Glu and hOGG1 Ser/Cys showed increased colorectal cancer risk (OR ¼ 6.37; 95% CI ¼ 1.40-29.02). 51 However, different results were obtained in Korean (OR ¼ 1.72; 95% CI ¼ 1.12-2.76 Ser/Cys, only meat intake), 47 Japanese (OR ¼ 1.43; 95% CI ¼ 0.69-2.95 for Ser/ Cys þ Cys/Cys) and Chinese populations (OR ¼ 1.4; 95% CI ¼ 0.9-2.2 for Ser/Cys; OR ¼ 1.4; 95% CI ¼ 0.9-2.1 for Cys/Cys). 52, 53 Another study in a Caucasian population showed no association of the OGG1 Cys/Cys genotype (OR ¼ 0.963; 95% CI ¼ 0.446-2.079) with the risk of cancer progression, despite the elevated oxidative stress in these cancer patients. 54 Wang et al. analyzed the distributions of three SNPs (XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln) in DNA repair genes, assessed the association of these genetic polymorphisms with colon and rectal cancer susceptibility, as well as evaluated the interactions of gene-gene and gene-environment in a case-control study of an Indian population. No association was observed between the XRCC1 Arg399Gln gene polymorphism and cancer risk (OR ¼ 1.44; 95% CI ¼ 0.76-2.75 for colon; OR ¼ 1.40; 95% CI ¼ 0.96-2.06 for rectal; OR ¼ 1.41; 95% CI ¼ 0.99-2.03 colorectal cancer). However, the XRCC1 Gln399 allele was associated with a significantly increased rectal cancer risk among men (OR ¼ 1.65; 95% CI ¼ 1.04-2.64), indicating a gender effect of this allele on colorectal cancer. Furthermore, individuals carrying XRCC1 Gln399, XRCC3 Thr/Thr (double-strand break repair) and XPD Gln751 demonstrated the highest colorectal cancer risk (OR ¼ 3.52; 95% CI ¼ 1. 43-9.44 ). 55 Environmental factors, such as diet, lifestyle and environmental pollution, have important impact on the development of colorectal cancer. Thus, Wang et al. also evaluated the interaction of gene-smoking or gene-alcohol on rectal or colorectal cancer risk. The XRCC1 Arg399Gln gene polymorphism was not found to be interacting significantly with tobacco consumption on cancer susceptibility (interaction p > 0.05, respectively). Conversely, there was a positive association of the XRCC1 Gln399 allele with rectal (OR ¼ 1.56; 95% CI ¼ 1.05-2.33) and colorectal (OR ¼ 1.61; 95% CI ¼ 1.11-2.34) cancer among nondrinkers, and there was a weak evidence that XRCC1 Arg/Arg genotype increased the risk of rectal (OR ¼ 1.93; 95% CI ¼ 0.94-4.04) or colorectal (OR ¼ 1.91; 95% CI ¼ 0.96-3.86) cancer among drinkers (p ¼ 0.05 for rectal cancer and 0.03 for colorectal cancer). Alcohol intake did not affect the results of the other genetic polymorphisms, that is, XRCC3 Thr241Met and XPD Lys715Gln (interaction p > 0.05, respectively). Finally, based on a small proportion of vegetarians in their study group, Wang et al. argued that the insufficient nutrition may explain some of the increased risk of rectal cancer (OR ¼ 1.83; 95% CI ¼ 1.04-3.26). Meta-analysis with a large population confirmed the previous studies, showing no association between XRCC1 gene polymorphisms and colorectal cancer. 56 Additional studies similarly found no association between XRCC1 Arg399Gln gene polymorphism and colorectal cancer risk. 46, 50, 52, 53 Lung cancer Table 2 summarizes the associations of gene polymorphisms and lung cancer. Lung cancer is one of the most common cancers and is the leading cause of cancer death worldwide. In 2006, there were an estimated 1,352,000 new lung cancer cases and 1,179,000 lung cancer deaths. The main types of lung cancer are small-cell lung carcinoma and NSCLC. There are three main subtypes: squamous cell lung carcinoma (SCLC), ADC and large-cell lung carcinoma. This distinction is important for therapy. SCLC is most strongly associated with smoking, while ADC is least strongly associated with smoking and the most common lung cancer in nonsmokers. Thus, genetic as well as environmental factors should be considered in developing and applying interventions. 33 The International Lung Cancer Consortium analyzed the correlation between DNA repair gene variants and lung cancer susceptibility using the data from 14 studies for 18 sequence variants in 12 DNA repair genes (APE1, OGG1, XRCC1, XRCC2, XRCC3, ERCC1, XPD, XPF, XPA, XPG, MGMT and TP53). Six studies were conducted in European countries, four in the United States and four in Asia or the Pacific Islands. Seven studies used hospital-based controls, seven studies used population-based controls and one study used a nested cohort study design. The number of subjects in these studies ranged from 2073 to 13,955. Relevant to the review here, we focused on the BER variants in OGG1, APE1 and XRCC1. OGG1 Ser326Cys homozygous variant individuals were associated with lung cancer risk in Caucasians (OR ¼ 1.34; 95% CI ¼ 1.01-1.79) based on 2569 cases and 4178 controls in four studies; however, this association was lacking in Asian populations. 18, 32, 57, 58 OGG1
Results

Colorectal cancers
Ser326Cys also showed a differential effect in non-Hispanic Whites in one study. 32 59 Similar observations were made in a Chinese hospital based case-control study. 8 In this study, individuals with a homozygous XRCC1 Gln/Gln genotype (OR ¼ 1.75; 95% CI ¼ 1.02-3.01) exhibited a slightly higher risk of lung cancer overall and the adjusted OR was increased in the cases with ADC (OR ¼ 2.62; 95% CI ¼ 1. 44-4.79) . No joint effect of cooking oil fume and Gln399 was observed on lung cancer risk in women nonsmokers. 8 No significant association was reported between OGG1 Ser326Cys and lung cancer risk.
In the first prospective population-based study of Danes, there were no associations between XRCC1 Arg280His and Arg399Gln or OGG1 Ser326Cys gene polymorphisms and risk of lung cancer. 60 Miyaishi et al. also did not find a significantly increased risk of lung ADC or SCLC with respect to OGG1 genotype (OR ¼ 1.39; 95% CI ¼ 0.61-3.19; Ser/Ser vs. Cys/Cys for ADC and OR ¼ 1.22; 95% CI ¼ 0.40-3.75; Ser/Ser vs. Cys/Cys for SCLC). 19 A larger hospital-based study performed in Turkey generally supported these results, although the OGG1 Ser326Cys polymorphism had a reduced lung cancer risk in smokers (Cys/Cys vs. Ser/Ser; adjusted OR ¼ 0.62; 95% CI ¼ 0.26-1.43). 61 Kohno et al. found that the effect of the OGG1 Ser326Cys gene polymorphism on lung ADC risk was not modified by smoking in this study population. 33 However, some lung cancer studies have suggested higher lung cancer risk associated with OGG1 Cys/Cys vs. Ser/Ser, 33, 62, 63 yet did not find an association between the XRCC1 Arg399Gln gene polymorphism and lung cancer risk. These inconsistencies highlight the difficulties associated with comparing different genotypes and different cancer subtypes. 64 
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Human and Experimental Toxicology 31(10) 66 Yin et al. found a significantly decreased risk of lung cancer associated with the Arg/His or His/His genotype of XRCC1 at position 280 (OR ¼ 0.38; 95% CI ¼ 0.19-0.75, Arg/His þ His/His vs. Arg/ Arg, p ¼ 0.005) in a larger population of 'neversmokers', while there was no interaction between Arg/His genotype and smoking. 67 In a populationbased cohort of 57,053 Danes, messenger RNA (mRNA) levels of OGG1, NEIL1 (nei endonuclease VIII-like 1 (Escherichia coli)), MUTYH (mutY Homolog (E. coli)) and NUDT and subsequent lung cancer risk was evaluated. Overall, mRNA levels of BER genes were not predictors of lung cancer risk. However, subjects with the OGG1 Cys/Cys genotype had a reduced expression level of OGG1 mRNA, and there was a positive association between the level and risk of lung cancer. Assuming that the amino acid substitution reduces repair capacity, as has been demonstrated in several independent studies, 68, 69 this observation might indicate that the expression of OGG1 is regulated by the level of oxidative DNA damage. Finally, the intracellular level of OGG1 Cys326 protein was directly correlated with urinary excretion of 8-oxoG, which could be interpreted as a biomarker of exposure to oxidative stress. 9 Table 3 summarizes the associations of gene polymorphisms and gastrointestinal cancer. Gastric cancer is the second leading cause of cancer death and the fourth most common epithelial neoplasia worldwide, with the highest incidence in China, Japan and Eastern European countries. 70 According to the GLOBO-CAN 2008 data, summary statistics indicate that the gastric cancer is fifth in males among the five most frequent cancers (prostate, lung, colorectal, bladder and stomach), whereas no gastric cancer is observed in females. 71 A variety of factors including sodium intake, Helicobacter pylori infection and smoking induce inflammation in the stomach. An inflammatory cell infiltrate in the gastric mucosa increases the production of ROS, which causes potentially mutagenic 8-oxoG lesions in the DNA. In mammalian cells, 8-oxoG is repaired by BER enzymes such as OGG1, MYH and NEIL1. In addition, MTH1, a part of the defense system against oxidative damage, removes 8-oxo-dGTP from the nucleotide pool, thus preventing incorporation of the base lesion into DNA during replication. OGG1-c.977C>G (Ser326Cys) was associated with a difference in 8-oxoG repair capacity, and MTH1-c.247G>A (Val83Met) has been reported to be associated with increased risk of gastric cancer. These results suggest that SNPs OGG1c.977C>G (Ser326Cys) and MTH1-c.247G>A (Val83Met) may lead to the accumulation of 8-oxoG in the gastric mucosa. 72 Li et al. conducted a population-based cohort study in China to evaluate the association between H. pylori-associated precancerous gastric lesions and the following polymorphisms: XRCC1, Arg399Gln and Arg194Trp; poly-ADP-ribose polymerase, Val762Ala; OGG1 Ser326Cys and APE1 Asp148Glu. An inverse association was found between XRCC1 Arg/ Trp þ Trp/Trp and progression of gastric lesions, suggesting that Trp194 allele may play a protective role in this population. The OGG1 Ser/Cys þ Cys/Cys genotype was associated with an increased risk of progression in subjects with intestinal metaplasia or dysplasia at baseline, indicating that the Cys326 allele was a deleterious allele in this high-risk population. 73 In the Korean population, a similar protective effect of Trp194 was observed. 74 In particular, the frequencies of Trp194 or Gln399 homozygotes were similar in the cases and controls and were not associated with a risk of gastric cancer upon adjustment for age and sex. However, with the Arg194Arg genotype as the reference group, the combined genotype (Arg/Trp and Trp/Trp) specific OR was 0.66 (95% CI ¼ 0.44-1.00, p ¼ 0:052), indicative of the 194Trp allele operating as a protective allele for gastric cancer. 76 
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Human and Experimental Toxicology 31(10) Malik et al. assessed the role of OGG1 Ser326Cys in susceptibility to gastric cancer in Kashmir valley, where the incidence is three to six times higher than various metropolis cancer registries in India. No association was observed. However, smoking habit showed significantly higher risk in gastric cancer patients harboring the OGG1 Ser/Cys genotype (OR ¼ 8.975; 95% CI ¼ 5.156-15.622; p ¼ 0.0001), suggesting that the gene-environment interactions are more important in the development of gastrointestinal cancer compared with colorectal cancer. Higher consumption of salted tea was also found to be associated with increased risk of gastric cancer. Individuals that consumed salted tea in a range of two to eight cups per day and individuals that consumed salted tea of more than four cups per day were regarded as high salted tea consumers. However, when taking potential gene-environment interactions into account, there was no association of OGG1 Ser326Cys gene polymorphism with smoking and salted tea consumption. Therefore, the authors concluded that although the OGG1 Ser326Cys gene polymorphism is reported to be a risk factor in some cancers, it does not appear to play a major role in gastric cancer development in Kashmir valley. 75 Yan et al. did not find any significant difference in allele and genotype distributions of XRCC1 Arg/Trp or Arg/Gln genotypes between gastric cardia adenocarcinoma (GCA) and controls. However, smokers with the His allele at codon 280 had a significantly increased risk of GCA. 76 Since the Arg280His variant occurs in the proliferating cell nuclear antigen binding region, 77 the transition from a positively charged Arg to His within the conserved region could alter specific XRCC1 functions. For the XRCC1 Arg194Trp gene polymorphism, no association was found for the risk of GCA, 76 consistent with previous results conducted in China and Korean. 73, 74 In contrast, Yuan et al. found that the XRCC1 Trp194 allele significantly increased the risk of gastric cancer and also associated with the risk of gastric cardia carcinoma and promoted distant metastasis of gastric cancer. 78 Thus, there are conflicting results on the association between gastric cancer and XRCC1 or OGG1 gene polymorphisms. These discrepancies may reflect differences in the study population or cancer location. Indeed, noncardia gastric cancer risk is positively associated with H. pylori infection, but cardia cancer is not. Ethnic differences may also influence gastric cancer risk. Palli et al. carried out a multigenic study on gastric cancer with polymorphic DNA repair and metabolic genes. A significant interaction of the APE1 wild type genotype was observed with either the single GSTT1 or double GSTM1-GSTT1 null genotype or the XPA mutant allele, with APE1 being protective for cancer susceptibility. 79 Bladder cancer Table 4 summarizes the associations of gene polymorphisms and bladder cancer. In our previous work, we found the OGG1 Cys/Cys genotype to be more frequent among bladder cancer patients (OR ¼ 2.41; 95% CI ¼ 1. 36-4.25) . However, no association was observed in the Arg399Gln gene polymorphism and the risk of bladder cancer (OR ¼ 0.72; 95% CI ¼ 0.41-1.26). 80 Huang et al. observed similar results regarding the XRCC1 Arg399Gln gene polymorphism, but did not find any association with the OGG1 Ser326Cys gene polymorphism and bladder cancer risk. 64 Breast cancer Table 5 summarizes the associations of gene polymorphisms and breast cancer. Studies suggest that breast cancer is initiated by somatic mutations that may have been introduced during error-prone repair of estrogen-induced abasic sites. 81 However, SNPs may modulate breast cancer risk, including XRCC1 Arg194Trp and Arg399Gln, APE1 Asp148Glu and OGG1 Ser326Cys. Sigurdson et al. evaluated 19 SNPs in eight genes involved in BER (e.g. XRCC1 and APE1), interactions with BRCA1 (BRIPI, ZNF350 and BRCA2) or growth regulation (TGFb1 and IGFBP3). XRCC1 Arg194Trp and Arg399Gln polymorphisms were associated with increased breast cancer risk (XRCC1 Arg/Arg vs. Arg/Trp þ Trp/Trp, cumulative risk up to age 70 years, risk ratio (RR) ¼ 2.3, 95% CI ¼ 1.3-3.8; Arg/Arg vs. Gln/Gln, RR ¼ 1.9, 95% CI ¼ 1.1-3.9, respectively). However, APE1 Asp148Glu was associated with a significantly lower risk than the homozygous genotype (RR ¼ 0.2, 95% CI ¼ 0.1-0.5, Asp/Asp vs. Glu/Glu, cumulative risk up to age 70 years, p < 0.001). No associations were observed for the polymorphisms in the other genes noted above. Moreover, the study indicated that some XRCC1 variants in combination with BRCA1 are low penetrance breast cancer risk alleles. 82 Recently, a study was conducted by Ali et al. on US women who carried XRCC1 Arg399Gln variant, but not the commonly reported APE1 Glu148 variant.
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Human and Experimental Toxicology 31(10) Table 5 . This study reported that XRCC1 Gln399 may enhance the risk of breast cancer. 81 Although individual DNA repair genotypes might have a small effect, combined nsSNPs in multiple DNA repair pathways may have a larger effect on cancer risk. Smith et al. analyzed 18 nsSNPs in four DNA repair pathways in Caucasians and African Americans to evaluate potential associations with breast cancer risk. Their data suggested that in Caucasians, breast cancer risk was significantly associated with APE1 Asp/Glu genotype (OR ¼ 1.44; 95% CI ¼ 1.03-2.00, Asp/Glu þ Glu/Glu); this association was not observed in African Americans due to limited sample size. 83 Two large population-based studies (one in the United States and one in Poland), a hospital-based cohort study in Denmark and one hospital-based study in Taiwan found no significant association between OGG1 Cys/Cys (Cys/Cys vs. Ser/Ser; adjusted OR ¼ 1.00; 95% CI ¼ 0.7-1.4 and OR ¼ 0.98; 95% CI ¼ 0.52-1.86; Ser/Ser vs. Cys/Cys for cohort study) or XRCC1 Gln/Gln (Gln/Gln vs. Arg/Arg, adjusted OR ¼ 0.8; 95% CI ¼ 0.7-1.109) and breast cancer risk. 84 A smaller Taiwan hospital-based breast cancer study concurred with this result 83 data were adjusted for age, body mass index (BMI), family history of breast cancer in first-degree relatives, age at menarche, age at first full-term pregnancy, parity, age at menopause, menopausal status, hormone replacement therapy and highest level of education. In the Taiwan population, a significantly increased breast cancer risk was found for the Cys/Cys genotype (Cys/Cys vs. Ser/Ser; OR ¼ 2.05; 95% CI ¼ 1.14-3.69) in postmenopausal women. [84] [85] [86] Yuan et al. investigated the effect of OGG1 Ser326Cys gene polymorphism on the susceptibility to breast cancer with data collected in a meta-study, since the published studies on OGG1 Ser326Cys polymorphism and breast cancer risk had inconsistent conclusions. The meta-analysis suggested that the hOGG1 Cys326 allele is associated with significant protection against breast cancer in European women. 87 Table 6 summarizes the associations of gene polymorphisms and gynecologic cancers and/or disorders. Cervical cancer, including squamous cell carcinoma (SCC), ADC and adenosquamous cell carcinoma (ADSC) subtypes, is the third most common cancer worldwide. Cervical cancer is associated with persistent human papillomavirus infection in the minority of cases. Polymorphisms in the OGG1 and XRCC1 genes were not associated with cervical cancer risk. 88 In a hospital-based epidemiologic study conducted in Japan, there was no significant association between the XRCC1 Arg399Gln gene polymorphism and risk of cervical cancer, when all histologic subtypes were included. 88 However, ADC/ADSC was associated with Arg/Gln (OR ¼ 2.98; 95% CI ¼ 1.11-8.01 for Gln/Gln and OR ¼ 2.18; 95% CI ¼ 1.11-4.26 for Arg/ Gln þ Gln/Gln in ADC and ADSC), whereas SCC was not. Similar data for Gln/Gln were observed in never smokers (OR ¼ 3.85; 95% CI ¼ 1.28-11.59, p ¼ 0.017), but not among smokers. 88 Endometriosis is a common, benign, estrogendependent, chronic gynecological disorder. Although multiple theories exist regarding the etiology of endometriosis, the exact pathogenesis remains uncertain. A recent study on a Turkish population showed no association between XRCC1 Arg399Gln, XRCC3 Thr241Met, XPD Lys751Gln, XPD Asp104His, APE1 Asp148Glu and hOGG1 Ser326Cys and endometriosis risk. 42 However, the study sample size was very small (52 patients and 110 controls).
Gynecologic cancers and disorders
Uterine leiomyoma is the most common gynecological benign tumor of the myometrium. It is a significant cause of pelvic pain, abnormal uterine bleeding, infertility and pregnancy complications. Many factors including age, family genetics, emotional status, hormone levels and environmental factors may contribute to the development of this disease. One study investigated whether the different XRCC1 codon polymorphisms were related to the occurrence of uterine leiomyoma in a Chinese population. 89 These investigators found a significant risk associated with codon 280 (OR ¼ 3.633; 95% CI ¼ 2.147-6.148; Arg/Arg vs. Arg/His), but no association with codons 399 and 194. However, the sample size again was small (n ¼ 136), and further studies are therefore needed. 89 esophagus). 36 Furthermore, although no association between OGG1 genotype and orolaryngeal cancer risk was found in never smokers, significantly increased risk was observed in Cys/Cys smokers. 36 Hashimoto et al. confirmed this latter observation regarding the relationship of Cys326 and smoking status with cancer susceptibility (OR ¼ 8.10; 95% CI ¼ 1.06-61.73 for OGG1 Cys/Cys). 90 For XRCC1, the polymorphic variants at codons 399, 194 and 280 were associated with increased risk of oral cancer in an Indian population. Moreover, smokers and betel quid chewers with the variant allele of XRCC1 at position 399 also exhibited increased risk of oral cancer. 91 The XRCC1 Arg194Trp gene polymorphism was associated with increased risk of head and neck cancer in Korean and Hungarian populations, [92] [93] [94] whereas no associations were reported for the other XRCC1 polymorphisms. In a separate study, Kowalski et al. observed an increase risk with only Arg/Trp plus Trp/Trp genotypes at codon 194. 93 In the US population, no association was found with APE1 Asp148Glu and XRCC1 Arg399Gln, Arg280Trp and Arg194Trp gene polymorphisms and head and neck cancer risk. 94 The others Table 8 summarizes the associations of gene polymorphisms and different cancer types (skin, acute lymphoblastic leukemia (ALL), head and neck, prostate, non-Hodgkin Lymphoma (NHL), brain, lung and UADC), with further discussion in each of the sections to follow.
Upper aerodigestive cancer
Skin cancer. Sun exposure, but not history of sunburn, is recognized as an important risk factor for skin cancer development. Kang et al. found lower risk of SCC associated with XRCC1 Arg194Trp and higher risk of basal cell carcinoma (BCC) associated with the Arg399Gln variant. 4 Another study suggests that XRCC1 Arg280His and Arg399Gln genotypes are risk factors for skin cancer. 95 A well-designed nested case-control study undertaken by the Danish prospective cohort 'Diet, Cancer and Health' involved 319 cases carefully matched with 319 controls recruited from a cohort of 57,053 Danes. However, no association was found between the OGG1 Ser326Cys and risk of BCC (OR ¼ 0.98, 95% CI ¼ 0.70-1.37; for Ser326Cys, OR ¼ 1.09; 95% CI ¼ 0.59-2.03 for Cys/Cys). The lack of association may reflect low environmental exposure to sunlight in Denmark or selection of the OGG1 SNP and this skin cancer subtype. 60 Acute lymphoblastic leukemia. ALL is characterized by improper development and differentiation of lymphoid progenitor cells. It is the most common childhood cancer with a peak at 2 + 5 years of age. 96 The influence of the Arg194Trp, Arg280His and Arg399Gln polymorphisms of XRCC1 on the development of childhood ALL was investigated in 120 patients and 120 controls in Mexico. No significant difference was observed between patients and controls (OR ¼ 1.71, 95% CI ¼ 0.65-4.48 for Arg/Arg vs. Gln/Gln, OR ¼ 2.15; 95% CI ¼ 0.52-8.89 for Arg/Arg vs. Trp/Trp and OR ¼ 2.02; 95% CI ¼ 0.18-22.72 for Arg/Arg vs. His/His). 97 The lack of association for the XRCC1 Trp194 and Gln399 variants with ALL was similarly observed in Turkish children. 98 However, Matullo et al. found a 2.5-fold increased risk of ALL in patients carrying the Gln/Gln genotype. 99 Prostate cancer. Prostate cancer (PCa) is one of the most common malignancies in men in the Western countries and accounts for 31% of new annual cancer cases in men. The incidence of PCa varies greatly with race and geography. 100 Xu et al. investigated individual and joint effects of the three polymorphisms in XRCC1 on PCa risk. The194 Arg/Trp genotype was associated with lower risk of PCa than wild type, while Arg280His had no impact on PCa risk. Compared with wild type, Arg399Gln variant alone was associated with a statistically significant increased risk of PCa (adjusted OR: 3.19; 95% CI ¼ 1. 48-6.88) . When the three polymorphisms (Arg194Trp, Arg280His and Arg399Gln) were evaluated in combination, subjects with a Arg/Arg, Arg/His and Arg/Gln genotype had a significantly higher risk of PCa (adjusted OR ¼ 4.31; 95% CI ¼ 1. 24-14.99 ). 101 Non-Hodgkin lymphoma. NHL represents a heterogeneous group of lymphocytic disorders ranging in aggressiveness from indolent to highly aggressive and rapidly proliferative. Although it is the fifth cause of cancer mortality in the United States, NHL remains poorly understood and is largely incurable. 102 Wellknown risk factors include family history, immune dysfunction (e.g. autoimmune diseases, immune deficiency syndromes and iatrogenic immunosuppression after organ transplant), immune stimulation and infection (e.g. human T-lymphotrophic virus type I and 996
Human and Experimental Toxicology 31(10) Gall bladder tract cancers. The gallbladder is susceptible to ROS-induced DNA damage, lipid peroxidation and biliary stasis. Since XRCC1 and OGG1 play important roles in the repair of oxidative DNA damage. Srivastava et al. investigated the role of OGG1 Ser326Cys and XRCC1 Arg399Gln gene polymorphisms in gallbladder cancer (GBC) susceptibility. The frequency of the variant OGG1 Cys/Cys genotype in female GBC patients was significantly higher than in controls (OR ¼ 5.92; 95% CI ¼ 1. 20-29.13 ). However, this significance vanished when Ser/Cys þ Cys/Cys genotypes were combined and compared with wild type. Disease risk due to the OGG1 Ser326Cys polymorphism in female GBC patients may be due to gallstone complications, which are more predominant in females, or may reflect the larger sample size of this group. In GBC, the Cys allele may be recessive, so that homozygote carriers could potentially have increased risk of the disease. 44 The frequency of XRCC1 Arg/Gln and Gln/Gln genotypes for codon 399 was significantly different from controls (p ¼ 0.039 and 0.003, respectively) and conferred low risk of GBC; a trend test was also significant (p ¼ 0.001 for trend). Another study on biliary system cancer was performed by Huang et al. They found that XRCC1 Arg/Gln and OGG1 Cys/Cys genotypes were unrelated to GBC risk and suggested that the replication in future epidemiological studies is required to confirm the association of biliary tract cancer with the polymorphisms in OGG1 and XRCC1 genes. 106 Brain tumors. XRCC1 Arg399Gln, Arg194Trp and Arg280His gene polymorphisms were not significantly associated with the risk of brain tumors; however, homozygous Gln/Gln showed a nearly statistically significant association with risk of all brain tumor types (i.e. glioma, glioblastoma and meningioma; OR ¼ 1.32; 95% CI ¼ 0.97-1.81; OR ¼ 1.48; 95% CI ¼ 0.98-2.24 and OR ¼ 1.34; 95% CI, 0.96-1.86, respectively). There was no significant difference in the risk of brain tumors between carriers and noncarriers of the variant XRCC1 alleles Trp194 and His280. 107 Thyroid carcinoma. Thyroid cancer is the most prevalent endocrine malignancy, and the incidence rate has increased in recent decades. The relationship between Arg399Gln, Arg280His, Arg194Trp in XRCC1 or Asp148Glu in APE1 and the risk of differentiated thyroid carcinoma and regional lymph node (LN) metastasis was examined. Only XRCC1 Arg194Trp was identified as having a possible association with the risk of thyroid cancer and LN, which may be increased by SNPs in other DNA repair genes. 108 
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Human and Experimental Toxicology 31 (10) Discussion DNA damage is generated by a variety of endogenous and exogenous chemical and physical agents. To prevent the potentially mutagenic or lethal consequences of DNA modifications, cells have evolved a series of complementary yet distinct DNA repair processes. The BER pathway copes with most spontaneous forms of DNA damage, including oxidative lesions such as base modifications, abasic sites and singlestrand breaks. Not surprisingly, there is evidence that deficiencies in BER are associated with elevated risk of cancer, neurodegenerative disease and premature aging phenotypes. Thus, for the past decade or more, epidemiologists have determined the association of specific SNPs in BER genes with susceptibility to a range of cancer types, with or without a relevant exposure. We present in this review a summary of several key molecular epidemiology studies focused on the OGG1 Ser326Cys, APE1 Asp148Glu and XRCC1 Arg399Gln, Arg280His and Arg194Trp polymorphic variants. Based on the articles reviewed herein, we conclude the following. 109 The conclusions regarding breast cancer risk and BER polymorphisms are also based on a limited number of studies. 6. UADC is another smoking related cancer type.
Thus, smoking interacts strongly the risk of UADC in individuals with OGG1 Ser326Cys and XRCC1 Arg399Gln or Arg194Trp polymorphism. 7. For skin cancer and other cancers (Table 8) , the most studied polymorphisms are XRCC1 Arg399Gln, Arg194Trp and Arg280His. A twoto fourfold increased cancer risk has been observed with these polymorphisms and each of these cancer types. Cancer subtypes are important and modulate the risk of cancer. For example, while Arg/Trp genotype reduces the risk of SCC, Arg/Gln genotype increases the risk of BCC. For GBC, a strong association with OGG1 Cys/Cys in females was reported. However, this association disappeared when genotypes were combined (Ser/Cys þ Cys/Cys).
It still remains somewhat unclear whether the polymorphisms in OGG1 Ser326Cys, APE1 Asp148Glu or XRCC1 Arg399Gln, Arg280His and Arg194Trp directly or indirectly affect either protein levels or activities, which would be instrumental in modifying risk of different cancer types 37 (see further discussion in the study by Wilson et al. 37 ). However, while we advocate prospective examination of the associations between polymorphisms and cancer risk, it is always difficult to unambiguously incorporate environmental risk factor data (smoking, drinking, diet, etc.) into gene polymorphism-cancer association analysis due to uncertainties about the past. Thus, in some studies, alternative definitions for the environmental risk factors were used to try to resolve this problem. Nevertheless, simple and common study designs to evaluate gene polymorphism-cancer association have been the case-control approach. This method is easier and cheaper than other alternative protocols, although it may cause substantial bias and spurious associations as most required expectations cannot be met. Also, case-control studies on genetically homogenous or heterogynous populations may modify the results of the analysis. Epidemiological investigations of DNA repair polymorphisms must be adequately designed with respect to sample size and the selection of polymorphisms and due to the small sample size of most of the studies to date, inconsistent results can be expected. Only six studies considered in this review had a sample size more than 1000, 12, 33, 46, 62, 84 and these studies would be expected to give more accurate results with greater statistical power. In general, a large sample size reduces false-positive and falsenegative results and provides more reliable data. It can, however, be very difficult to enroll enough patients for comprehensive association studies. Moreover, it is difficult to carry out multicentric hospital-and population-based studies in some countries. Furthermore, in most developing countries, follow-up studies and use of survey instruments are difficult. This leads to a small sample size in studies that are performed in developing countries. For example, in Turkey, it is very hard to get enough samples to carry out Genome Wide Association Studies (GWAS) or to obtain good statistics showing cancer frequencies.
In addition to the rationale, targeted SNP association studies described herein, GWAS are an important approach for discovering genetic variants influencing cancer risk. GWAS permits interrogation of the entire human genome at levels of resolution previously unattainable, in thousands of unrelated individuals, while many other approaches are biased by specific hypotheses regarding disease mechanism. On the other hand, to rule out false positive GWAS results, statistical analyses must be held to very high stringency and study replication is essential to account for biased representation in the study population and/or genotyping errors. For this reason, meta-analyses may be more valuable. However, meta-analyses also has limitations, such as (a) eligibility criteria for inclusion of subjects and sources of controls may differ among studies; (b) it is difficult to rule out incipient cancer in the controls and (c) gene-gene and gene-environment interactions may not be addressed because of the lack of sufficient data. Another weak aspect of GWAS is that many polymorphisms have different distributions and frequencies in different populations or geographic regions and consequently, association studies in mixed populations may produce false positive results. Confounding factors such as diet, smoking status, hormonal status and BMI should be considered in all GWAS studies. The selection of gene variants is also important and should consider functional outcome and phenotypic effect. Gene-gene interactions and their synergistic or additive effects should be considered as well as cancer type, stage or grade, patient ethnicity and population structure. DNA repair activity, when considered, should be quantified using the most accurate available methods, and/or multiple methods, where possible. mRNA or protein levels can also be used for additional evidence of DNA repair capacity.
Conclusion
In conclusion, to fully understand the role of DNA damage and DNA repair in the carcinogenesis, prospective studies are needed and additional genes should be analyzed. Such studies should investigate mRNA expression, DNA damage levels and DNA repair capacity and should consider gene-environment and gene-gene interactions.
